Logo image
Se connecter
Retour
Treatment strategies to resectable metachronous colorectal liver metastases after adjuvant oxaliplatin‐based chemotherapy for primary colorectal cancer
Article de revue   Avec comité de lecture

Treatment strategies to resectable metachronous colorectal liver metastases after adjuvant oxaliplatin‐based chemotherapy for primary colorectal cancer

Camille Julio, Stephane Benoist, Marc‐antoine Allard, Francis Navarro, Patrick Pessaux, Antonio Sa Cunha et Antoine Brouquet
Journal of Surgical Oncology, Vol.126(2), pp.330-338
09/08/2022
DOI: https://doi.org/10.1002/jso.26885

Résumé

hepatic recurrence, liver resection, metachronous, preoperative chemotherapy
Outcome of patients who develop resectable metachronous colorectal liver metastases (CLM) after adjuvant oxaliplatin‐based chemotherapy for Stage III colorectal cancer (CRC) is not well defined and the value of preoperative chemotherapy is controversial.

Fichiers et liens (1)

url
Find in HALAfficher

Indicateurs

1 Consultations de la notice

Détails

Logo image